⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
AT2 Receptor (AT2R) in Cardiac Aging and Senescence
Current understanding
The Type 2 Angiotensin II receptor (AT2R) is proposed as a counter-regulatory arm of the renin–angiotensin system whose loss accelerates cardiac senescence, fibrosis, and NLRP3-inflammasome activation in aged mice, with a reported ~5-month shortening of median lifespan versus wild-type [animal-model]. Human translation is untested, and the pathway sits adjacent to — but distinct from — the AT1R-blocker cardioprotection literature that dominates current clinical RAS pharmacology.
Evidence log
- 2026-09-23 — Mitochondrial Transplantation Rejuvenates Aging Heart by Restoring Mitophagy Flux via the HIF‐3α‐BNIP3 Axis: cross-connection with mitochondrial-dysfunction: Adds mitochondrial transplantation to the cardiac-aging rejuvenation toolbox alongside AT2R and Asb2–KIF11 axes, sharing mitophagy/lysosomal-flux restoration as a proximal mechanism in the aged heart. (novelty: 3)
- 2026-09-14 — APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health.: cross-connection with vascular-aging: APOE:RAAS epistasis finding ties RAAS genetic variation (already implicated in AT2R-driven cardiac aging) to cerebrovascular/cognitive-aging endpoints, connecting the receptor-level RAAS story to a population-genetic vascular-cognition axis. (novelty: 3)
- 2026-09-22 — Asb2-KIF11 Axis Protects Against Heart Failure by Restoring Lysosomal Distribution and Mitochondrial Homeostasis.: cross-connection with asb2-kif11-cardiomyocyte-autophagy: Both propose cardiomyocyte-intrinsic molecular axes that reverse age-related and pressure-overload cardiac remodeling in mice; sit alongside each other as candidate cardiac-aging targets with no human data. (novelty: 3)
- 2026-09-14 — Clearance of p16-positive cardiac cells improves age-related cardiac remodeling in mice.: cross-connection with cellular-senescence: Both nominate senescent cardiac fibroblasts/cardiomyocytes as drivers of age-related cardiac remodeling; the p16-clearance data provide the causal-loss-of-function counterpart to AT2R-deficiency gain-of-senescence. (novelty: 3)
- 2026-09-25 — Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.: cross-connection with atip-at2-amyloid-pathology: Both invoke AT2 signaling as an aging-relevant lever, but in distinct tissues (cardiac senescence/fibrosis vs. brain amyloid pathology) — worth tracking together as the AT2R healthspan story develops across organs. (novelty: 3)
Open questions
Related
Contributing findings
Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.
25-sep-2026
novelty 3
per-area 3
introduces